Repurposing the Ionophore, PBT2, for Treatment of Multidrug-Resistant Neisseria gonorrhoeae Infections

Author:

Jen Freda E.-C.1,Edwards Jennifer L.2ORCID,El-Deeb Ibrahim M.1,Walker Mark J.3,von Itzstein Mark1ORCID,Jennings Michael P.1ORCID

Affiliation:

1. Institute for Glycomics, Griffith University, Gold Coast Campus, Queensland, Australia

2. The Center for Microbial Pathogenesis, The Abigail Wexner Research Institute at Nationwide Children's Hospital and The Department of Pediatrics, The Ohio State University, Ohio, USA

3. School of Chemistry and Molecular Biosciences and Australian Infectious Diseases Research Centre, The University of Queensland, Queensland, Australia

Abstract

Multidrug-resistant (MDR) N. gonorrhoeae is a current public health threat. New therapies are urgently needed. PBT2 is an ionophore that disrupts metal homeostasis. PBT2 administered with zinc is shown to reverse resistance to antibiotics in several bacterial pathogens. Here we show that both N. meningitidis and MDR N. gonorrhoeae are sensitive to killing by PBT2 alone. PBT2 is, thus, a candidate therapeutic for MDR N. gonorrhoeae infections.

Funder

Department of Health | National Health and Medical Research Council

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference26 articles.

1. Tackling antibiotic resistance

2. Multiresistant Gram-negative infections: a global perspective

3. Antibacterial resistance worldwide: causes, challenges and responses

4. WHO. 2019. Sexually transmitted infections fact sheet. https://apps.who.int/iris/bitstream/handle/10665/112323/WHO_RHR_14.10_eng.pdf;jsessionid=6921B7BF04C72E67C5FBB20256DB72C4?sequence=1.

5. CDC. 2013. Antibiotic resistance threats in the United States. https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf-page=55.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3